Blood coagulation parameters after intravitreal injection of aflibercept in patients with neovascular age-related macular degeneration
- 152 Downloads
The aim of this study was to evaluate the effect of intravitreal injection of aflibercept (IVA) on blood coagulation tests in neovascular age-related macular degeneration (AMD) patients.
Thirty-four patients with neovascular AMD (study group) and 32 healthy individuals (control group) were enrolled. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) were measured at different times in patients with neovascular AMD.
The levels of PT and aPTT after IVA were decreased at 1 month after the first injection and 1 month after the second injection compared to the baseline measurement in the study group.
IVA may cause a decrease in the levels of PT and aPTT at 1 month after the first injection and 1 month after the second injection although these results are not statistically significant in our study.
KeywordsActivated partial thromboplastin time Age-related macular degeneration Aflibercept Arterial thrombotic events Prothrombin time
Compliance with ethical standards
Conflict of interest
The authors declare no financial or proprietary interests.
The study protocol followed the principles in the declaration of Helsinki.
Informed consent was obtained from all individual participants included in the study.
- 29.Ng EWM, Adamis AP (2005) Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 40:353–368Google Scholar